20.500.12556/DiRROS-30771 Lipid clinics worldwide harmonization and guidance on how to optimally organize and fund: European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics Because one in three of all individuals die from atherosclerotic cardiovascular disease (ASCVD), prevention of ASCVD is key to public health worldwide. Lipid clinics provide specialized diagnostic assessment, lifestyle management, and evidence-based lipid-lowering treatment to prevent ASCVD and acute pancreatitis in high-risk individuals. This includes individuals with familial hypercholesterolemia and/or markedly increased lipoprotein(a), statin intolerance, refractory or difficult-to-control low-density lipoprotein (LDL) cholesterol, severe hypertriglyceridaemia, and other rare or complex lipid disorders. Such specialized care not only benefits the individual patients and their families but facilitates dissemination of best practices in lipid disorder management to healthcare professionals in individual nations. Despite this, there is a lack of guidance on standards and metrics needed to establish a well-harmonized national lipid clinic network in most countries capable of offering comprehensive care. This consensus paper from the European Atherosclerosis Society Lipid Clinic Network aims to meet this unmet clinical need. We provide recommendations to enhance education and training on lipid disorders and to harmonize lipid clinics at both national and international levels. Furthermore, we provide guidance on optimal staffing structures and development of registries to improve diagnosis and management of lipid disorders. Finally, we offer recommendations to national and regional policymakers on funding of lipid clinics, with the long-term goal of reducing the overall societal burden and costs of cardiovascular and other lipid-related diseases. hyperlipidaemia hypolipidaemia prevention myocardial infarction stroke atherosclerosis true false true Angleški jezik Ni določen Neznano 2026-07-02 10:00:40 2026-07-02 10:00:41 2026-07-03 10:46:45 0000-00-00 00:00:00 2026 0 0 Nasl. z nasl. zaslona; Opis vira z dne 8. 6. 2026; str. 1-22 [article no.] 120757 Vol. 418 2026 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616.1 1879-1484 10.1016/j.atherosclerosis.2026.120757 280754691 RAZ_Bork_Christian_2026.pdf RAZ_Bork_Christian_2026.pdf 1 6C699E48C49DD83AC3A543D5C686AE49 bdde8e9947da13eef4f06714a6d279f2633c03e4dd67626185704f6b5f16f7bb 9b3dbbf0-75ec-11f1-a2b4-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=47023 https://www.atherosclerosis-journal.com/article/S0021-9150(26)00123-1/fulltext 1 1fcd598a-75ec-11f1-a2b4-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=47022 Univerzitetni klinični center Ljubljana 0 0 0